This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer: There's No Market Smell Test

The political types are already citing the new health care regime as a reason to sell stocks, but that might prove to be wrong because the large companies are precisely the ones that can navigate these new waters. Their smaller-capitalization and private small-company rivals are the ones that should fall by the wayside. That will soon be seen as logical, but a lack of business savvy by the White House didn't see this coming any more than it didn't see the Web site issues coming.

So, to sum up, the smell test does get vindicated back-handedly by the transition that has historically occurred now. The investing that has come previous to this moment is from people who recognize that bad news has historically led to good news and they have been driven by individual stock performance as well as pattern recognition. The asset-class hunters and the corporate buybacks have been convenient props to the whole process, which is why this move that is so explosive, the one that shouldn't be happening, is indeed prevailing.

I feel badly for those who wait for things to smell better. They may not know history. They might be confused by politics and the need to have a balance between a bull and a bear debate driven by politics. But they, in the end, shouldn't be pitied. They convinced themselves they were right and by doing so they were perfectly willing to forgo the gains to date.

I think they will most likely forego the next set of gains, too. A combination of blindness from the inability to believe that stocks can really rally under Obama, coupled with an underestimation of the Federal Reserve's will, abetted by the nonpolitical historical buyers who are not now going to turn sellers precisely because they know the history and fear a stock shortage among seasoned equities -- the IPO market has provided tons of unseasoned and often disrespected fodder -- could end up propelling us to the next level. Oh, and believe me, to these purists, that advance will stink to high heaven, too.

Must Read: The Penney Drops as Clearance Stockpiles

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, had no positions in stocks mentioned.

Editor's Note: This article was originally published at 7:24 a.m. EST on Real Money on Dec. 9.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs